Fecal microbiota transplantation in the intestinal decolonization of carbapenamase-producing enterobacteriaceae

Rev Esp Enferm Dig. 2020 Dec;112(12):925-928. doi: 10.17235/reed.2020.7150/2020.

Abstract

Background and aims: fecal microbiota transplantation (FMT) is effective for recurrent Clostridium difficile infection (CDI). Intestinal decolonization of carbapenamase-producing enterobacteriaceae (CPE) can prevent transmission and infection by these agents. The aim of this study was to assess CPE decolonization after FMT.

Methods: this was a case-series study that consecutively included all CPE-carriers that underwent FMT between 2014 and 2019. The indications included refractory/recurrent CDI and CPE-decolonization.

Results: out of 21 CPE-carriers, eight were excluded due to incomplete post-FMT testing. CPE decolonization was confirmed in 76.9 % (n = 10). The median decolonization time was 16-weeks (IQR-23) and ranged from two to 53 weeks.

Conclusion: FMT may be used in the clinical practice for CPE-decolonization as an alternative to combined antibiotic regimens.

MeSH terms

  • Clostridium Infections*
  • Enterobacteriaceae
  • Fecal Microbiota Transplantation*
  • Feces
  • Humans
  • Intestines
  • Recurrence
  • Treatment Outcome